Cryo-Cell International, Inc. Stock Other OTC
Equities
CCEL
US2288951088
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 31.78M | Sales 2025 * | 35.21M | Capitalization | 64.19M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 1M | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
264
x | P/E ratio 2025 * |
66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 97-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
Harold Berger
BRD | Director/Board Member | 60 | 11-08-24 |
1st Jan change | Capi. | |
---|---|---|
-11.82% | 87.77B | |
+14.64% | 82.08B | |
+13.31% | 30.03B | |
-10.66% | 17.08B | |
-5.65% | 14.45B | |
+4.48% | 12.37B | |
-31.05% | 11.89B | |
+4.40% | 12.17B | |
+26.50% | 11.62B |